Explore the latest findings from the KATHERINE, PATINA, and HER2CLIMB-05 trials, highlighting advancements and challenges in breast cancer treatment.
The presence of circulating tumor DNA (ctDNA) in patients with human epidermal growth factor receptor 2 (HER2)-positive ...
A previously unknown mechanism that makes it possible for aggressive so-called triple-negative breast cancer to fine-tune its ...
News-Medical.Net on MSN
Researchers discover how aggressive breast cancer controls protein production
A previously unknown mechanism that makes it possible for aggressive so-called triple-negative breast cancer to fine-tune its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback